Inderal XL (Propranolol HCl) Patent Expiration, LOE Window & CMS Spending

Inderal XL (Propranolol HCl) by Ani: Off-Patent Genericized (AB Competition), 19 AB generics, $1.7M 2024 CMS Part D & Medicaid spend, and $2,543 CA SB 17 specialty launch WAC.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorAni
FDA Application & PathwayN018553 (NDA)
Exclusivity / Cliff HorizonOff-Patent Genericized (AB Competition)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity DateNot listed / N/A
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors19
2024 CMS Total Public Spend$1.7M
2024 Medicare Part D Spend$1.1M
2024 Medicaid Spend$607K
Reported Wholesale Price Change (CA SB 17)Specialty launch notice ($2,543 intro WAC)